Status:
RECRUITING
Development and Validation of a Blood Test for Early Diagnosis of Colorectal Cancer
Lead Sponsor:
ADVANCED MARKER DISCOVERY S.L.
Conditions:
Colorectal Carcinoma
Advanced Adenomas (AA)
Eligibility:
All Genders
18+ years
Brief Summary
This is a prospective, multicenter, case-control study. The aim is to develop an optimized algorithm by combining the levels of molecular markers in plasma together with risk factors for developing co...
Eligibility Criteria
Inclusion
- Patients over the age of 18 who are able to understand the participant information and sign the informed consent.
- Patients who are going to undergo colonoscopy or surgical resection for tumor (CRC).
Exclusion
- Patients who had developed any type of cancer in the 5 years prior to their participation in this study.
- Patients who have received previous chemotherapy or radiotherapy.
- Patients diagnosed with non-advanced adenomas, serrated polyps, Familial Adenomatous Polyposis or Lynch Syndrome.
- Patients with inadequate bowel preparation for colonoscopy.
- Patients who have undergone colonoscopy/polipectomy in the previous 5 years.
- Patients with hemolyzed plasma.
Key Trial Info
Start Date :
June 6 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
510 Patients enrolled
Trial Details
Trial ID
NCT06889883
Start Date
June 6 2023
End Date
December 31 2025
Last Update
October 1 2025
Active Locations (9)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Clinico Universitario Lozano Blesa
Zaragoza, Aragon, Spain
2
Hospital Universitario de Cruces
Bilbao, Basque Country, Spain
3
Policlinica Gipuzkoa Hospital
Donostia / San Sebastian, Basque Country, Spain
4
Hospital Universitario Marques de Valdecilla
Santander, Cantabria, Spain